Dispersion Polymerization versus Emulsifier-Free Emulsion Polymerization for Nano-Object Fabrication: A Comprehensive Comparison

Morphology Control of Polymer-Inorganic Hybrid Nanomaterials Prepared in Miniemulsion: From Solid Particles to Capsules

The preparation of so-called hybrid nanomaterials has been widely developed in terms of functional and morphological complexity. However, the specific control of the arrangement of organic and inorganic species, which determines the properties of the final material, still remains a challenge. This article offers a review of the strategies that have been used for the preparation of polymer-inorganic hybrid nanoparticles and nanocapsules via processes involving miniemulsions. Different polymer-inorganic nanostructures are classified into four main groups according to the sequential order followed between the synthesis of the polymer and the inorganic species, and the presence or not of their counterpart precursors. The minimization of the energy of the system governs the self-assembly of the different material components and can be addressed by the miniemulsion formulation to reduce the interfacial tensions between the phases involved. The state of the art in the preparation of hybrid nanoparticles is reviewed, offering insight into the structural possibilities allowed by miniemulsion as a versatile synthetic technique.

Copper Nanodrugs with Controlled Morphologies through Aqueous Atom Transfer Radical Polymerization

Copper (Cu) nanodrugs can be facilely prepared through atom transfer radical polymerization (ATRP) in an aqueous medium. However, it is difficult to control the morphology of Cu nanodrugs and thereby optimize their anticancer activity. In this work, aqueous ATRP was combined with polymerization-induced self-assembly (PISA) to prepare Cu nanodrugs with various morphologies. We mapped the relationship between polymerization condition and product morphology in which each morphology shows a wide preparation window. Decreasing the reaction temperature and feeding more Cu catalysts can improve the mobility of chains, facilitating the morphology evolution from sphere to other high-order morphologies. The resultant Cu nanodrugs with high monomer conversion and high Cu loading efficiency could be easily taken by cancer cells, showing excellent anticancer efficacy in vitro. This work proposed a potential strategy to prepare Cu nanodrugs with a specific morphology in batches, providing the method to optimize the anticancer efficacy through morphology control.

Recent developments in the use of nanocrystals to improve bioavailability of APIs

Nanocrystals refer to materials with at least one dimension smaller than 100 nm, composing of atoms arranged in single crystals or polycrystals. Nanocrystals have significant research value as they offer unique advantages over conventional pharmaceutical formulations, such as high bioavailability, enhanced targeting selectivity and controlled release ability and are therefore suitable for the delivery of a wide range of drugs such as insoluble drugs, antitumor drugs and genetic drugs with broad application prospects. In recent years, research on nanocrystals has been progressively refined and new products have been launched or entered the clinical phase of studies. However, issues such as safety and stability still stand that need to be addressed for further development of nanocrystal formulations, and significant gaps do exist in research in various fields in this pharmaceutical arena. This paper presents a systematic overview of the advanced development of nanocrystals, ranging from the preparation approaches of nanocrystals with which the bioavailability of poorly water-soluble drugs is improved, critical properties of nanocrystals and associated characterization techniques, the recent development of nanocrystals with different administration routes, the advantages and associated limitations of nanocrystal formulations, the mechanisms of physical instability, and the enhanced dissolution performance, to the future perspectives, with a final view to shed more light on the future development of nanocrystals as a means of optimizing the bioavailability of drug candidates. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.

Reversible chain transfer catalyzed polymerization in miniemulsion systems with tetraiodomethane as a catalyst

Tetraiodomethane (CI4) is an effective catalyst in reversible chain transfer catalyzed polymerization (RTCP) of methacrylate monomers in miniemulsion polymerization systems (miniemulsion RTCP).